DMA: The Evolution of Diagnostics through Deep Metabolism Analysis

We are made of energy. As scientist Jean Piquard states, every living being is a perfect electromagnetic machine because, like any other component of the natural environment, humans are capable of emitting electromagnetic waves. Our bodies and organs communicate with the outside world through a codifiable language that transforms the intangible into the tangible, conveying information about a part or the entirety of our being through devices known as biosensors.

For instance, tests like the Electrocardiogram and Electroencephalogram are well-known for detecting waves produced by the heart and brain and converting them into data. These are among the more familiar and routinely verified evidences, whereas, in reality, electric fields concern the entire human body, even with weaker currents and voltages that are equally significant for understanding a person’s health condition.

In this context, Math Biology’s interest in understanding metabolism and its processes is driven by the desire to enhance diagnostics and therapies across various fields—from medicine to wellness and sports—providing stakeholders with investigative and therapeutic tools characterized by maximum efficiency, minimal invasiveness during implementation, and the ability to customize the approach based on the intended goals.

Combining over 13 years of experience in pharmaceutical research with studies in biology and metabolic principles, the company has been developing protocols and software that correlate Human Surface Current Measure (HSCM)—current measurements taken under specific conditions—with the state of particular organs, glands, and the central nervous system, generating crucial data about an individual’s Metabolic Profile Measurement (MPM).

DMA, or Deep Metabolism Assessment, encompasses studies concerning metabolic processes and their evidences, further enhanced by integrating technologies from the field of Artificial Intelligence. This operational methodology’s multiple benefits are observable at social, economic, scientific, and industrial levels.

Consider that, on one hand, the possibility of pre-screening leads to reduced costs for Public Health Systems by avoiding ineffective tests or therapies, while on the other, accessing customized care offers a dual benefit: for the pharmaceutical world, where drug production and commercialization become more targeted, and most importantly for the patient, who avoids unnecessary or aggressive treatments. Additionally, the positive impact in the Life Science sector from embracing new research, machinery, methodologies, and products extends to the availability of additional healthcare services and accessible insurance solutions for the community.

Furthermore, another strength of DMA lies in its cross-sectoral development—it is a methodology applicable in various fields. Specifically, the plans of evaluation and treatment directed at physicians are DMA® Screening and DMA® Diagnostics, used respectively for in-depth investigations of metabolic processes and the assessment of levels and risk factors for certain diseases; DMA® Monitoring, aimed at examining alerts on already monitored patients; and DMA® Wellness & Sport, which, as the name suggests, supports professionals in addressing the psychophysical health status of their clients.